Lissiê Lunardi Sbroglio Viviane Maria Maiolini Irene Machado Moraes Alvarenga Rabelo Gabriela Almeida Giraldelli Luciana Patrícia Tuccori Rodrigo Guimarães Cunha
10.1590/0037-8682-0040-2020
Rev Soc Bras Med Trop
2020 Jun 22;53:e20200040.
CC BY
https://pubmed.ncbi.nlm.nih.gov/32578710/
Antiprotozoal Agents / administration & dosage Cocaine-Related Disorders / complications Leishmaniasis, Mucocutaneous / diagnosis Meglumine Antimoniate / administration & dosage
Antiprotozoal Agents / administration & dosage Cocaine-Related Disorders / complications Leishmaniasis, Mucocutaneous / diagnosis Meglumine Antimoniate / administration & dosage Case Reports Adult Humans Leishmaniasis, Mucocutaneous / complications Leishmaniasis, Mucocutaneous / drug therapy Male Antiprotozoal Agents Meglumine Antimoniate
PMC7310364
32578710
Mucocutaneous leishmaniasis in a cocaine user: diagnostic and therapeutic knowledge
2020